MedPath

sefulness of Tolvaptan tablet over Furosemide injection in reducing swelling in Nephrotic syndrome

Not Applicable
Conditions
Health Condition 1: N042- Nephrotic syndrome with diffuse membranous glomerulonephritisHealth Condition 2: N045- Nephrotic syndrome with diffuse mesangiocapillary glomerulonephritisHealth Condition 3: N041- Nephrotic syndrome with focal andsegmental glomerular lesionsHealth Condition 4: N040- Nephrotic syndrome with minor glomerular abnormalityHealth Condition 5: N048- Nephrotic syndrome with other morphologic changesHealth Condition 6: N049- Nephrotic syndrome with unspecified morphologic changes
Registration Number
CTRI/2022/10/046590
Lead Sponsor
Department of Pediatrics
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Nephrotic syndrome aged between 5 and 14 years with moderate to severe edema

2) Patients not responding to oral furosemide for up to 24 hours (decrease in 3% body weight or urine output < 1 ml/kg/hour)

3) Parents willing to give informed written consent

Exclusion Criteria

1) Patients with hypovolemia

2) Patients with cerebral venous sinus thrombosis

3) Serum sodium < 125 or > 140 meq/L

4) eGFR < 60 ml/min/1.73 m2

5) SGOT/SGPT > 2 ULN

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
rine output over the first 48 hours (ml/kg/hr)Timepoint: 0 hours <br/ ><br>12 hours <br/ ><br>24 hours <br/ ><br>36 hours <br/ ><br>48 hours
Secondary Outcome Measures
NameTimeMethod
â?¢Percentage of weight loss over 48 hours <br/ ><br> <br/ ><br>â?¢Serum sodium every 12 hourly for 48 hours <br/ ><br> <br/ ><br>â?¢Urine and serum osmolality every 24 hours for 48 hours <br/ ><br> <br/ ><br>â?¢Urine sodium/ potassium/ creatinine every 24 hours for 48 hours <br/ ><br> <br/ ><br>â?¢Adverse effects <br/ ><br>Timepoint: 0 Hours <br/ ><br>12 hours <br/ ><br>24 hours <br/ ><br>36 hours <br/ ><br>48 hours
© Copyright 2025. All Rights Reserved by MedPath